We are live on
!
Find out more
iShares US Medical Devices ETF
543 hedge funds and large institutions have $2.14B invested in iShares US Medical Devices ETF in 2024 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 128 increasing their positions, 229 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
57% more call options, than puts
Call options by funds: $20.2M | Put options by funds: $12.9M
1.23% more ownership
Funds ownership: 40.52% → 41.75% (+1.2%)
7% less funds holding
Funds holding: 581 → 543 (-38)
8% less capital invested
Capital invested by funds: $2.33B → $2.14B (-$186M)
37% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 83
44% less repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 229
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Holders
543
Holders Change
-38
Holders Change %
-6.54%
% of All Funds
7.84%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.04%
New
52
Increased
128
Reduced
229
Closed
83
Calls
$20.2M
Puts
$12.9M
Net Calls
+$7.31M
Net Calls Change
-$16.6M
Top Buyers
| 1 |
Citigroup
New York
|
+$30M |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$18.9M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$15.7M |
| 4 |
NSLI
Nan Shan Life Insurance
Taipei City,
Taiwan
|
+$15.4M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$13.1M |
